*A/Wisconsin/67/2005/H3N2. **A/New Caledonia/20/99/H1N1. ***A/Singapore/57/H2N2. - = ≤1∶16 for HI, <1∶20 for SN. ∧ = Titres expressed as the highest dilution at which full haemagglutination inhibition
Distribution of study participants by age group, sex, RDT and sero-positivity to both MSP-119 and AMA-1 for health facilities in Korogwe and Same districts.
Abbreviations: 95% CI, 95% confidence interval; 100 PY, 100 persons-years of observation; IDU: intravenous drug user; IQR, interquartile range; MSM, men who have sex with men. Note: *Seroconversion fr
Background: Many serologic studies were done during and after the 2009 influenza pandemic, to estimate the cumulative incidence of influenza A(H1N1)pdm09 virus infections, but there are few comparativ
